P2.06-41 Differentiating Sarcomatoid Mesothelioma From Pleomorphic Carcinoma and Chest Wall Sarcoma Using GATA-3/MUC4/BAP1 IHC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1296
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.06-28 Assessment of Chest Wall Motion Using Structured Light Plethysmography (SLP) in Mesothelioma and Benign Pleural Disease

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MFH Classification: Differentiating Undifferentiated Pleomorphic Sarcoma in the 21st Century

Expert Review of Anticancer Therapy
OncologyPharmacology
2009English

A Study of GATA-3 in Malignant Pleural Mesothelioma

Pathology
Forensic MedicinePathology
2020English

OA03.01 the Immunophenotyping and Genomic Characteristics of Pulmonary Sarcomatoid Carcinoma: Pleomorphic, Spindle Cell and Giant Cell Carcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MUC4 Immunohistochemistry Is Useful in Distinguishing Epithelioid Mesothelioma From Adenocarcinoma and Squamous Cell Carcinoma of the Lung

Scientific Reports
Multidisciplinary
2018English

Clinical Indications and Results After Chest Wall Resection for Recurrent Mesothelioma

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2013English

Undifferentiated Pleomorphic Sarcoma

2020English

Chest Wall Sarcoma of Childhood With a Good Prognosis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1978English

Germline BAP1 Mutations Predispose to Malignant Mesothelioma

Nature Genetics
Genetics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy